Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · IEX Real-Time Price · USD
0.310
+0.016 (5.44%)
Jul 22, 2024, 9:57 AM EDT - Market open
Sunshine Biopharma Employees
Sunshine Biopharma had 44 employees as of December 31, 2023. The number of employees decreased by 2 or -4.35% compared to the previous year.
Employees
44
Change (1Y)
-2
Growth (1Y)
-4.35%
Revenue / Employee
$607,722
Profits / Employee
-$92,896
Market Cap
7.26M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telesis Bio | 147 |
| Pulmatrix | 22 |
| Notable Labs | 16 |
| GlucoTrack | 6 |
| Tenax Therapeutics | 6 |
| Virios Therapeutics | 4 |
| Cadrenal Therapeutics | 4 |
| Xenetic Biosciences | 4 |
SBFM News
- 3 months ago - Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R) - Accesswire
- 3 months ago - Sunshine Biopharma Announces Reverse Stock Split - Accesswire
- 4 months ago - Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023 - Accesswire
- 5 months ago - Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering - Accesswire
- 5 months ago - Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering - Accesswire
- 8 months ago - Sunshine Biopharma Moves Principal Office to New York City - GlobeNewsWire
- 9 months ago - Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition - Accesswire
- 10 months ago - Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance - Accesswire